Chronic obstructive pulmonary disease and oxidative stress.

Area of Science:

• Pulmonary Medicine
• Oxidative Stress Research
• Respiratory Cell Biology

Background:

• The respiratory tract is a primary entry point for inhaled substances, leading to excess reactive species.
• Heavy smokers are at high risk for developing, worsening, and experiencing treatment failure in chronic obstructive pulmonary disease (COPD).
• Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are implicated in respiratory diseases, with effects often studied in airway epithelial cells.

Purpose of the Study:

• To provide an updated review on the influence of ROS and RNS on COPD, focusing specifically on the airways.
• To discuss the role of oxidative stress induced by cigarette smoke in COPD pathogenesis.
• To explore potential future therapeutic strategies using genomic medicine for COPD.

Main Methods:

• Review of existing literature on ROS/RNS and COPD.
• Analysis of authors' original studies on fine particulate matter and trace elements in lung biopsies.
• Focus on cellular effects of ROS/RNS in respiratory epithelial cells.

Main Results:

• Cigarette smoke induces significant oxidative stress in the respiratory tract.
• Inhalation of particulate matter and trace elements disrupts the oxidant-antioxidant balance in lung tissue.
• ROS and RNS species, while generally stable, exhibit diverse cellular reactivity.

Conclusions:

• Oxidative stress from inhaled substances, particularly cigarette smoke, plays a critical role in COPD development and progression.
• Imbalance in oxidant-antioxidant homeostasis is a key feature of COPD airways.
• Genomic medicine offers promising, albeit emerging, avenues for future COPD therapeutic interventions.